What is low dose naltrexone?

Low Dose Naltrexone otherwise known as LDN, is typically taken at/around bedtime typically taken for diseases such as Crohn's disease and multiple sclerosis.

Low dose naltrexone is available only at compounding pharmacies. Our pharmacists will compound the correct dose in an easy to swallow capsule. Feel free to call and talk to a member of our staff if you are interested or have additional questions.


Multiple Sclerosis

Rahn, K., McLaughlin, P. and Zagon, I. (2011)
Frech, T., Novak, K., Revelo, M., Murtaugh, M., Markewitz, B., Hatton, N., Scholand, M., Frech, E., Markewitz, D. and Sawitzke, A. (2011)
Gironi, M., Martinelli-Boneschi, F., Sacerdote, P., Solaro, C., Zaffaroni, M., Cavarretta, R., Moiola, L., Bucello, S., Radaelli, M., Pilato, V., Rodegher, M., Cursi, M., Franchi, S., Martinelli, V., Nemni, R., Comi, G. and Martino, G. (2008)

Crohn's Disease

Ccfa.org, (2016). CCFA: What is Crohn's Disease | Causes of Crohn's.
Segal, Dan, John K Macdonald, and Nilesh Chande.
Smith, J., Field, D., Bingaman, S., Evans, R. and Mauger, D. (2013)
Smith, J., Bingaman, S., Ruggiero, F., Mauger, D., Mukherjee, A., McGovern, C. and Zagon, I. (2011)
Lichtenstein, G., Hanauer, S. and Sandborn, W. (2009)
Smith, J., Stock, H., Bingaman, S., Mauger, D., Rogosnitzky, M. and Zagon, I. (2007)
Raknes, G., Simonsen, P., and Smabrekke, L. (2018)


Woeller, K. (2009). Autism - The Benefits of Low Dose Naltrexone. [Blog] DR. KURT WOELLER - BIOMEDICAL AUTISM INTERVENTION.
McCandless, J. (2006)
Bouvard, M., Leboyer, M., Launay, J., Recasens, C., Plumet, M., Waller-Perotte, D., Tabuteau, F., Bondoux, D., Dugas, M., Lensing, P. and Panksepp, J. (1995).
Ing, B., Au, D. and Poland, R. (1993).
Campbell, M., Anderson, L., Small, A., Adams, P., Gonzalez, N. and Ernst, M. (1993).
Sandman, C. (1990).
Campbell, M., Overall, J., Small, A., Sokol, M., Spencer, E., Adams, P., Foltz, R., Monti, K., Perry, R., Nobler, M. and Roberts, E. (1989).


Lowdosenaltrexone.org, (2016).
Ldninfo.org, (2016).


Donahue, R., McLaughlin, P. and Zagon, I. (2011)


Younger, J. and Mackey, S. (2009)


Younger, J., Parkitny, L. and McLain, D. (2014)
Chopra, P. and Cooper, M. (2013).
Hamann, S. and Sloan, P. (2007).
Pape, W. and W├Âller, W. (2015).

Postural Orthostatic Tachycardia Syndrome (POTS) and Mast Cell Activation Syndrome (MCAS)

Brook, J., Goodman, B., Myers, T., and Weinstock, L. (2017).


Mischoulon, D., Hylek, L., Yeung, A., Clain, A., Baer, L., Cusin, C., Ionescu, D., Alpert, J., Soskin, D. and Fava, M. (2017)

Clinical Practice

Schwaiger, Timothy, Md. (2018).